![Ragnhild Marie Løberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ragnhild Marie Løberg
Geen lopende functies
Profiel
Ragnhild Marie Løberg formerly worked at Pronova AS, as Director-Galenical Department, Pronova Biocare AS, as Quality Director in 2002, and Algeta ASA, as Senior Vice President-Quality & Regulatory Affairs.
Ms. Løberg received her graduate degree in 1978 from the University of Oslo.
Eerdere bekende functies van Ragnhild Marie Løberg
Bedrijven | Functie | Einde |
---|---|---|
Pronova Biocare AS | Corporate Officer/Principal | 01-01-2002 |
ALGETA ASA | Algemeen Adviseur | - |
Pronova AS
![]() Pronova AS Investment Banks/BrokersFinance Part of Norsk Hydro ASA, Pronova AS provides non-marine broking services. | Corporate Officer/Principal | - |
Opleiding van Ragnhild Marie Løberg
University of Oslo | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Pronova AS
![]() Pronova AS Investment Banks/BrokersFinance Part of Norsk Hydro ASA, Pronova AS provides non-marine broking services. | Finance |
Algeta ASA
![]() Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
Pronova Biocare AS |